Chronic obstructive pulmonary disease (COPD) is not curable, but can be managed with appropriate medication. Various awareness programs have been initiated by healthcare providers and health organisations/societies such as environmental programs, medication maintenance programs and online education programs for public and healthcare professionals, which encourage people to adopt early medication. This factor is expected to play a key role in increased revenue of the global respiratory devices market over the forecast period. Healthcare providers and organisations are teaming up to improve and prevent respiratory diseases across the globe. AstraZeneca and 10 industry leaders are teaming up to prevent and control prevalence of respiratory disease in China.
North America to Lead the Global Market with Growing Disposable Income and Increasing Geriatric Population
Improvement in healthcare policies in various countries, such as the U.S., has enhanced the affordability for various diagnostic and treatment services, and in turn amplified the life expectancy of the people. The burgeoning ageing population will raise the number of people diagnosed with COPD and asthma. Overall management of asthma and COPD is very crucial and problematic after 65 years of age. People above 65 years who are diagnosed with asthma and COPD are unable to consume liquid medication. Airway clearances are thus turning out to be the ultimate choice as they convert liquid medication into aerosol or mist. Moreover, the rise in per capita income is influencing individuals to spend more on health care, as concerns regarding healthcare is increasing with increasing living standards. The other factors that are benefiting the North America airway clearance systems market are the expansion of third-party payer coverage by manufacturers, growth of home care and institutional market, high incidence rate of chronic diseases, employment of the Affordable Care Act, and the lowering cost of the treatment settings. However, it is yet to be seen that whether the strict regulation scenario act as a hurdle or not.
Europe to Witness Decent Growth in Upcoming Years
The cost structure of home care and hospitals or institutional services in Europe varies considerably owing to the quality of services offered by respiratory care service providers or manufacturers, which comprise other type of monitoring and hospitality services. The cost of OPEP and PEP devices ranges from US$ 45 to US$ 100. Nevertheless, the cost might get as high as US$ 20,000 in case of HCFWO. Home airway clearance devices are cheap as compared to in-lab study. The market for airway clearance systems is very competitive and has presence of Tier 1 and Tier 2 companies along with many small companies. These companies will be participating in several distribution partnerships to achieve a considerable market share during the course of the forecast period. Established market players have shaped a brand image and value over the years, which have made market penetration very complex for new players. Key players are shifting their focus towards the developent new and technologically advanced PEP, OPEP, IPV, and HCFWO devices to better serve the customers, while facing intense competition at a regional level. Hill Rom, PARI, Electromed, Philips Respironics, and several others are some of the major players in the European market.
Global Healthcare Sector Outlook
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Persistence Market Research presents thorough research study on the global airway clearance systems market. The report talks about all the aspects associated with airway clearance technology and systems, along with special emphasis on the key factors influencing the market scenario in the next few years. The report provides detailed analyses of market fields over 2017-2025.
PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information. Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics. Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier level based on their revenues, product portfolio and presence. Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
The global market for airway clearance systems market has been segmented into:
By Device Type
By Application Type
By End User
Specific Report Inputs
An analyst involved in the research study of the global airway clearance systems industry has taken into consideration the region-wise occurrence of the total number of respiratory diseases. The diagnosis rate has then been considered along with the data as to how many have opted for airway clearance and how many patients have chosen other treatment devices and methods.